Market: NMS |
Currency: USD
Address: One Kendall Square
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001 for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP to treat synaptic Ras GTPase activating protein 1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
📈 CAMP Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$8.75
-
Upside/Downside from Analyst Target:
118.20%
-
Broker Call:
10
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
50-100%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for CAMP
| Date | Reported EPS |
|---|
| 2025-11-06 | -0.54 |
| 2025-08-14 | -0.62 |
| 2025-08-12 | - |
| 2025-05-13 | -0.62 |
| 2024-11-21 | -24.19 |
📰 Related News & Research
-
Keppel Secures 10-Year Lease Extension for AI-Ready Data Centre Campus in Singapore, Boosting Keppel DC REIT Portfolio
December 26, 2025
Detailed Analysis Strategic Lease Extension: The granted 10-year lease extension for the Keppel Data Centre Campus is a pivotal development for both Keppel Ltd. and…
-
Keppel Secures 10-Year Lease Extension for AI-Ready Data Centre Campus in Singapore, Boosting Keppel DC REIT Portfolio
December 26, 2025
Keppel Secures 10-Year Lease Extension for AI-Ready Data Centre Campus: Financial Implications for Investors Keppel Secures 10-Year Lease Extension for AI-Ready Data Centre Campus: Financial…
-
IREIT Global Secures €12.5 Million Loan Facility from CDL Subsidiary for Berlin Campus Repositioning
December 25, 2025
IREIT Global Secures €12.5 Million Loan Facility from CDL Subsidiary to Fund Berlin Campus Project Key Highlights from the Announcement New Loan Facility: IREIT Global,…
-
IREIT Global 3Q2025 Business Update: European Real Estate Portfolio Performance, Asset Management, and Berlin Campus Repositioning
November 21, 2025
Overview IREIT Global, a pure-play Western Europe-focused real estate investment trust (REIT), released its 3Q2025 business update with significant developments across its portfolio, capital management,…
-
IREIT Global Secures €200 Million German Portfolio Refinancing, Extends Debt Maturity to 2029 and Adds €20 Million for Berlin Campus Upgrade
October 10, 2025
IREIT Global Secures €220 Million in Debt Refinancing, Extends German Portfolio Loan Maturity to 2029: What Investors Need to Know Key Points IREIT Global completes…
-
IREIT Global Q3 2024 Update: Portfolio Resilience, Berlin Campus Transformation, and Western European Real Estate Outlook
November 14, 2024
IREIT Global Shows Resilient Performance Amidst European Market Shifts IREIT Global Shows Resilient Performance Amidst European Market Shifts In its 3Q2024 business update, IREIT Global…
-
IREIT Global’s Bold Move: Betting on Berlin Campus Transformation Amid European Real Estate Uncertainty
November 13, 2024
IREIT Global Reports Stable 3Q2024 Performance Despite Challenges in Spanish Portfolio IREIT Global Reports Stable 3Q2024 Performance Despite Challenges in Spanish Portfolio IREIT Global has…
🔍 View more Reports
